Previous Article | Next Article ![]()
Eukaryotic Cell, July 2006, p. 1007-1017, Vol. 5, No. 7
1535-9778/06/$08.00+0 doi:10.1128/EC.00045-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Department of Biological Sciences, University at Albany/SUNY, Albany, New York 12222
Received 14 February 2006/ Accepted 3 May 2006
|
|
|---|
|
|
|---|
Ssn6 and Tup1 are expressed constitutively and have no intrinsic DNA-binding activity (29, 45). The gene or regulon specificity of repression is controlled through specific DNA-binding proteins that recruit the general repression complex. Thus, for example, Rox1 represses the hypoxic genes (2, 35); Mig1 and -2, the glucose-repressed genes (48, 51); Rfx1 (Crt1), the DNA damage-repair genes (22); and
2-Mcm1, the a mating type genes (29, 31, 37, 46). In each case the transcription, activity, or cellular compartmentalization of these DNA-binding repressors is regulated to control when repression is effected (10, 22, 31, 34, 35, 36, 46).
Our studies have focused on the regulation of the hypoxic genes (reviewed in references 28, 56, and 57). These genes are repressed aerobically by Rox1, which binds to Ssn6 to recruit the general repression complex. ROX1 expression is dependent upon heme, the synthesis of which requires molecular oxygen. Hence under hypoxic conditions, heme levels are low, Rox1 is not made, and the Ssn6/Tup1 complex is not recruited to the hypoxic genes. Consequently, these genes are derepressed. Despite the large protein complex that localizes to the regulatory region of Rox1-repressed genes, including Ssn6/Tup1, positioned nucleosomes, deacetylases, and perhaps the general transcription machinery, repression is dependent on the number and quality of the Rox1-binding sites; a base pair change in a Rox1 site that caused a fewfold decrease in Rox1 binding in vitro resulted in a proportional decrease in repression in vivo (9). Recently, an additional DNA-binding protein, Mot3, was found to augment repression by Rox1. Strong hypoxic repression sites consist of a combination of Rox1 and Mot3 sites (27, 30, 35, 44). For example, the ANB1 gene is repressed 250-fold, 8-fold by operator B which consists of two Rox1 sites, and 76-fold by operator A, which contains two Rox1 sites flanking a Mot3 site (27). The HEM13 gene is repressed 50-fold by three Mot3 sites plus one Rox1 site (30). We have termed this repression combinatorial repression. Combinatorial repression can be additive or synergistic. Additive repression occurs when the two repressors act independently. While Rox1 can repress independent of Mot3, Mot3 can only repress independently through multiple sites, with each bound Mot3 molecule acting independently of the others. Synergy is defined as the two repressors combining to repress gene expression to a greater extent than the additive effects of the single proteins acting independently. Synergy results when Rox1 and Mot3 bind to closely spaced sites. This synergy does not result from an interaction between the two proteins but rather through each repressor's interaction with the Ssn6/Tup1 complex (30). Chromatin immunoprecipitation experiments demonstrated that Rox1 bound to DNA independently of Mot3 and enhanced Mot3 binding (30, 35). These findings and others led us to propose a model for the synergistic interaction. Rox1 interacts weakly with the Ssn6/Tup1 complex, and the role of Mot3 is to help recruit the general repression complex. On the other hand, Mot3 interacts weakly with DNA and requires Rox1 binding to DNA strengthen its interaction through Ssn6/Tup1 (30).
This model requires no hypoxic specificity on the part of Mot3 when it functions through synergistic interactions with Rox1. Indeed, although Mot3 is repressed under hypoxia (44), constitutive expression of Mot3 did not result in any repression of ANB1 during hypoxia (35). Since synergy requires no direct interaction between Rox1 and Mot3, and if Mot3 cannot repress alone through a single site, we posited that Mot3 could function in the same capacity at other Ssn6/Tup1 regulons. The Mot3 binding site, (A/C/T)AGG(C/T)A, is only 6 bp and degenerate (19), so that it has a 50% chance of appearing once every 340 bp in a random sequence. Consequently, we only scanned the regulatory regions of Ssn6/Tup1 repressed genes with well-characterized regulon-specific DNA binding sites, searching for Mot3 sites close to those sites. We found promising hits in the regulatory region of DNA damage-inducible RNR3 and -4 genes encoding two of the proteins of ribonucleotide diphosphate reductase (RNR) (15, 21, 49). To our surprise, we also found Rox1 binding sites in these two genes as well as in RNR2, encoding another RNR subunit (14, 23). In the present study, we demonstrate that these genes are regulated by oxygen through Rox1 and Mot3 and that both Mot3 and Rox1 can function synergistically with Rfx1. In hindsight, these results are not surprising; the formation of the active RNR enzyme requires molecular oxygen (4, 17), and, therefore, this enzyme falls in the class of those whose concentrations must increase to compensate for limiting oxygen concentrations under hypoxia. The results reported here indicate that synergy between repressors allows substantial derepression under conditions that relieve only one repressor' s activity, thus providing dual regulation without the need to evolve new regulatory patterns for the repressors.
|
|
|---|
rfx1 with RZ53-6
mot3 to obtain a mot3
rfx1
double deletion. This strain was backcrossed to RZ53-6 or RZ53-6
rox1 to obtain the MZ series of strains listed in Table 1. |
View this table: [in a new window] |
TABLE 1. Yeast strains
|
Gradient plates used to assay cell sensitivity to 4-nitroquinoline-1-oxide (NQO) were made by first pouring yeast extract-peptone-dextrose (YPD) agar with 2.6 µM NQO into plates at an angle so that the agar solidified with a thin layer at one end and a thick layer at the other. Then, a second layer of YPD agar was poured over the first with the plates lying flat. The plates were used the same day. Cells to be tested were grown overnight to stationary phase and then diluted 50-fold and distributed into a 96-well microtiter dish. Drops were then stamped onto the plates, which were then incubated for 2 days at 30°C.
Plasmids.
The plasmid YCp(33)ROX1Z is a centromeric URA3 vector with the ROX1 upstream region from a HindIII site at 1290 to a PstI site at +4 fused to the lacZ coding sequence and the ANB1 3' sequences (8). YCp(33)AZ
B is a centromeric URA3 vector containing the ANB1 gene sequences from positions 568 to +977 with an in-frame insertion of the lacZ coding sequence. The ANB1 regulatory region contains a deletion of operator B (positions 213 to 187) (9). YCp(33)AZ
B
5' and YCp(33)AZ
B
3' were derived from YCp(33)AZ
B and contain deletions of the 5' or 3' Rox1 binding sites, respectively (9). YCp(33)AZ
B(10) and YCp(33)AZ
B(5) are derivatives of YCp(33)AZ
B with a 10-bp or a 5-bp deletion between the Rox1 binding sites, respectively (9). YCp(22)MOT3 (30) and YCp(23)MOT3HA (35) are centromeric TRP1 vectors containing the MOT3 gene without and with the HA epitope, respectively. YCp(23)ROX1HA and YCp(22)ROX1 are centromeric TRP1 vectors containing the an hemagglutinin (HA)-tagged ROX1 and an untagged ROX1 allele, respectively (35).
All plasmids were constructed by using standard procedures (1). Enzymatic reactions were carried out under the conditions recommended by the vendor (New England Biolabs, Inc., Beverly, MA). Synthetic oligonucleotides were purchased from Sigma-Genosys (The Woodlands, TX). Genes are numbered with the A in the translational initiation codon at +1, and bases 5'-wards in negative numbers. The references to 5' and 3' ends of and directions along sequences refer to the coding strand.
YCp(33)RNR2Z, YCp(33)RNR3Z, YIp(211)RNR3Z, and YCp(33)RNR4Z. The upstream regions of RNR2 (957 to +18), RNR3 (891 to +3), and RNR4 (988 to +3) were PCR amplified from genomic DNA with primers that placed an EagI (RNR2) or a HindIII (RNR3 and RNR4) at the upstream end and a PstI site in the coding sequence. The fragments were digested with the enzymes described above and inserted into YCp(33)ROX1Z digested with EagI plus PstI (for RNR2) or HindIII plus PstI (for RNR3 and RNR4). In the resulting plasmids, the RNR regulatory sequences replaced those of ROX1.
The integrating plasmid YIp(211)RNR3Z was constructed by subcloning the RNR3Z HindIII-XmaI fragment from YCp(33)RNR3Z into the corresponding sites of YIplac211 (18). This plasmid contained a unique AvrII at 330 within the RNR3 regulatory region. The plasmid was digested with this enzyme and transformed into yeast to integrate the entire plasmid into the RNR3 locus.
YCp(33)AZ-M3R1.
The upstream region of ANB1 was amplified from positions 568 to 311 using YCp(33)AZ
B as a template, a 3'-wards upstream primer that hybridized to vector sequences, and a 5'-wards downstream primer that contained an XhoI site, followed by a Rox1 binding site, a Mot3 binding site, an EagI restriction site, and then the ANB1 sequences from 311 to 334. The resulting fragment was digested with XhoI plus HindIII and ligated into YCp(33)AZ
B digested with the same enzymes. The resulting construct contained a deletion of the ANB1 operator B and A (275 to 313). OpA was replaced with one Rox1 and one Mot3 sites flanked by the restriction sites for EagI and XhoI. The inserted sequence is listed in Table 2.
|
View this table: [in a new window] |
TABLE 2. Inserts with combinations of binding sites
|
YIp(211)AZ-M3Rfs was constructed by subcloning the ANB1-lacZ HindIII-KpnI fragment from YCp(33)AZ-M3Rfs into the corresponding sites of YIplac211. This plasmid contained a unique BglII site within the ANB1 sequences 3' to the lacZ coding sequence. The plasmid was digested with this enzyme and transformed into yeast to integrate the entire plasmid into the ANB1 locus.
ß-Galactosidase and immunoblot assays. ß-Galactosidase assays were performed on pooled transformants (30). Transformants were selected on SC-uracil plates and, after several days of growth, the colonies on each plate were pooled and used to start overnight cultures. Cells were grown in SC-uracil medium to mid-exponential phase, and the enzyme assays were carried out as described previously (26). The data presented represent at least three independent assays with the standard deviations shown.
For immunoblots, cells were grown on selective media to mid-exponential phase, 1.5-ml samples were chilled, and the cells were harvested by centrifugation, resuspended in 40 µl of sodium dodecyl sulfate gel sample buffer, and boiled for 5 min. The samples were fractionated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and immunoblots were carried out as described previously (1). The blots were probed with monoclonal antibody against the HA epitope (Santa Cruz Biotechnology, Inc., Santa Cruz, CA). After the bands were visualized, the blot was stripped and reprobed with antisera against eIF5A (prepared by Alexander Kastaniotis). The ratio of HA to eIF5A was determined by using ImageQuant software (Amersham Biosciences, Piscataway, NJ).
|
|
|---|
![]() View larger version (14K): [in a new window] |
FIG. 1. Arrangements of repressor sites in the RNR genes. The upstream regions of the RNR2, RNR3, and RNR4 genes are presented. The sequences are numbered in negative integers from the first base preceding the ATG translational initiation codon, 1, 5'-wards to 800. The Rox1 sites are indicated as open boxes with a diagonal stripe, Mot3 sites are indicated as gray boxes, the strongly binding Rfx1 sites are designated as black boxes and the weakly binding Rfx1 sites are indicated as open boxes.
|
deletant (the combined Mot3-Rfx1 effect) to that in the rox1
rfx1
deletant (the Mot3 effect alone) and in the rox1
mot3
deletant (the Rfx1 effect alone) and in the triple deletant (complete derepression). The fold repression for this set of comparisons was calculated by dividing the ß-galactosidase activity in the fully derepressed triple deletant by that in the rox1
cells, the rox1
mot3
deletant, or the rox1
rfx1
deletant. We then calculated the synergy factor, defined as the fold repression by Mot3 alone (enzyme activity in rox1
mot3
rfx1
/rox1
rfx1
cells) times the fold repression by Rfx1 alone (enzyme activity in rox1
mot3
rfx1
/rox1
mot3
cells) divided into the fold repression by both repressors (enzyme activity in rox1
mot3
rfx1
/rox1
cells). This comparison assumes that independent, or additive, repression should be measured using the product of the effects of Rfx1 and Mot3 alone rather than the sum, because we envision repression through a single repressor occurring whenever the repressor is bound. Therefore, the fraction of time a gene can be expressed is the fraction of time when neither repressor is bound, or the product of the fold repression by the two repressors alone. This is a conservative estimate of additive repression, and we feel more confident assigning synergy using this assumption. A synergy factor of 1.0 represents additive repression, whereas a value significantly higher than 1 indicates synergy. For the example above, the synergy factor was 4.7, indicating a synergistic interaction between Mot3 and Rfx1 at RNR3. |
View this table: [in a new window] |
TABLE 3. Repression of the RNR2 gene
|
|
View this table: [in a new window] |
TABLE 5. Repression of the RNR4 gene
|
|
View this table: [in a new window] |
TABLE 4. Repression of the RNR3 gene
|
cells and in the rfx1
and mot3
rfx1
mutants. Rox1 alone repressed expression of RNR2 2.3-fold, the ratio of enzyme activity in rox1
rfx1
to that in the rfx1
cells, and Rfx1 alone repressed expression 11-fold, the ratio of enzyme activity in rox1
rfx1
to that in the rox1
cells. The synergy factor was calculated as 1.8, a value that is suggestive, but not conclusive, that these repressors act synergistically at this gene.
As expected from previously reported results (15, 22), the expression of the RNR3-lacZ was most strongly repressed, showing a nearly 1,800-fold difference between the enzyme activity in wild-type cells and cells carrying the triple deletion (Table 4). This repression was achieved by synergy between Mot3 and Rfx1 (a synergy factor of 4.7) and Rox1 and Rfx1 (a synergy factor of 44) but not between Rox1 and Mot3 (a synergy factor of 1.2). Any one of the repressors alone effected weak repression as seen in the double mutants; for example, Rfx1 alone repressed RNR3 expression only about twofold (the ratio of enzyme activity in the triple deletant to that in the rox1
mot3
strain). Interestingly, the strongest repression by a single repressor is the effect by Mot3, 9.3-fold in the rox1
rfx1
mutant, and this probably resulted from the three adjacent sites close within 100 bp of the start of translation.
RNR4-lacZ expression was repressed by all three repressors. Synergy was clearly indicated between Rox1 and Rfx1, but we have some reservations about the calculation of synergy involving Mot3. The enzyme activity measured in the triple deletant was somewhat lower than that determined for the rox1
rfx1
strain, which resulted in a fold repression of less than 1, making the synergy factor calculation suspect. Although the reason for this discrepancy is not known, the fact that there is only one Mot3 site adjacent to an Rfx1 site suggests that Mot3 can act synergistically with Rfx1 but not independently; hence, no repression in the rox1
rfx1
mutant. This Mot3 effect is the same as that observed in ANB1 where Mot3 could not repress in the absence of Rox1 (27, 30).
It is interesting that despite the different effects of the three repressors, the RNR2 and -4 fusions appear to be expressed at very similar levels in wild-type cells and in the triple deletion. These genes encode the small subunit of the RNR enzyme (14, 21, 23, 49) and are probably required in equivalent concentrations in the cell. The lacZ fusions used in the present study contain the upstream region and one or six codons of the beginning of the coding sequences of the RNR genes only; the 3' noncoding and transcriptional termination signals are those of the ANB1 gene. Thus, the levels of enzyme activity measured from these fusions may accurately represent the relative levels of transcription of the native genes.
It should be noted that, in cases in which synergy was clearly evident, the binding sites for the interacting repressors were within 30 bp of each other. When sites were 40 bp or greater apart, synergy was not seen, as in the case of the Mot3 and Rox1 sites in RNR3. However, the strength of the synergy was not predictable. Other factors, such as the intervening sequences, the location of undefined activation sequences, and the distance of the sites from the TATA box, may play roles in the strength of the synergy.
Finally, to address the concern that the results obtained with these RNR-lacZ fusions might be influenced by changes in the plasmid copy number in the different mutant strains, we integrated the RNR3-lacZ fusion into the genomic RNR3 locus in the wild-type and seven mutant strains. The ß-galactosidase assays were repeated, and the results are presented in Table 6. Clearly, there were differences in the levels of expression of RNR3-lacZ. In most, but not all cases, the measured enzyme activity was lower. The levels of repression calculated were also not identical, but the synergy values calculated for the three pairwise interactions proved to be consistent. Using a centromeric plasmid, the synergies calculated for Rfx1-Mot3 and Rox1-Mot3 were 4.7 and 1.2, respectively, whereas the corresponding values obtained with the integrated plasmid were 8.6 and 1.2, respectively. While the synergy factors calculated for Rfx1-Rox1 were very different (44 for experiments with the centromeric plasmid and 152 for those with the integrated reporter), both indicate strong synergy. Overall, despite quantitative differences, the conclusions with both constructs are identical.
|
View this table: [in a new window] |
TABLE 6. Repression of integrated RNR3-lacZ
|
allele, which not only causes derepression of RNR2 to -4 but also other genes whose products may help protect the cell from NQO (53). Clearly, the rox1
allele alone also caused increased NQO resistance, and resistance was further enhanced in combination with the rfx1
allele. No significant affect was observed with the mot3
allele.
![]() View larger version (46K): [in a new window] |
FIG. 2. Mutations in the repressor genes increased cell resistance to DNA damage. Wild-type and mutant cells were stamped onto a gradient plate containing NQO from 0 to 2.6 µM (right to left) as described in Materials and Methods. The cells were MZ233-20 (WT), MZ233-2 (mot3 ), MZ233-13 (rfx1 ), RZ53-6 rox1 (rox1 ), RZ56-6 r1 m3 (rox1 mot3 ), MZ233-6 (mot3 rfx1 ), MZ255-6 (rox1 rfx1 ), and MZ269-8 (rox1 mot3 rfx1 ).
|
and the rox1
mot3
mutants, respectively. On the other hand, Rfx1 alone still repressed under anaerobic conditions, as determined by the 11-fold repression of RNR2-lacZ both aerobically and anaerobically (rox1
rfx1
/rox1
) and the 2.1-fold aerobic and 5-fold anaerobic repression of RNR3-lacZ (rox1
mot3
rfx1
/rox1
mot3
). These results indicate that Rfx1 is not regulated either positively or negatively by oxygen (and, by inference, Rox1 and/or Mot3); this repressor gave the same levels of repression both aerobically and anaerobically. |
View this table: [in a new window] |
TABLE 7. Anaerobic expression of RNR2 and -3
|
![]() View larger version (12K): [in a new window] |
FIG. 3. Anaerobiosis and DNA damage induced RNR2Z and -3Z expression. MZ233-20 (wild-type) cells were transformed with either YCp(33)RNR2Z (A) or YCp(33)RNR3Z (B), and a 50-ml culture was grown aerobically to mid-exponential phase in SC-uracil supplemented with 0.2% Tween 80 and 20 µg of ergosterol/ml. A sample was taken for time zero, and then the cultures were divided into four flasks. A final concentration of 1.3 µM NQO was added to two of the flasks. Nitrogen was bubbled through the cultures, and time points were taken (see Materials and Methods). The results are plotted as Miller units versus the hours of anaerobic growth either in the absence (NQO) or presence (+NQO) of the DNA-damaging agent.
|
and mot3
rfx1
mutants were transformed with a plasmid carrying the MOT3HA allele, and the rox1
and rox1
rfx1
mutants were transformed with a plasmid carrying the ROX1HA allele. As can be seen in Fig. 4, there was no difference in the levels of Mot3HA (Fig. 3A) or Rox1HA (Fig. 3B) in RFX1 or rfx1
cells. Furthermore, the addition of NQO to RFX1 cells did not alter the levels of either Rox1HA or Mot3HA over a 3-h period. The blots were also probed for the translation factor eIF5A as a loading control. The relative levels of Mot3HA or Rox1HA, normalized to that of eIF5A, are presented below each lane.
![]() View larger version (26K): [in a new window] |
FIG. 4. Rox1 and Mot3 levels were not regulated by Rfx1 or NQO. (A) An immunoblot was carried out with protein extracts from MZ233-2 (a mot3 strain designated wild type [WT] here because it carried the MOT3HA allele on a plasmid) and MZ233-6 (a mot3 rfx1 strain designated rfx1 here because it carried the MOT3HA allele on a plasmid) cells transformed with YCp(23)MOT3HA, and MZ233-2 (lane C) cells transformed with YC(22)MOT3. Cells were grown aerobically in SC-tryptophan medium. DNA damage was induced in MZ233-2 cells transformed with YCp(23)MOT3HA by the addition of NQO to a final concentration of 1.3 µM, and samples were taken at the times indicated. The blots were probed with monoclonal antibody against the HA epitope (Mot3-HA) and then stripped and reprobed with polyclonal antibody to eIF-5A. The relative levels of Mot3HA compared to the wild type are indicated below each lane, calculated as follows. The density of Mot3HA signal in each lane was divided by that for eIF5A in that lane. Then, this normalized level was divided by that for Mot3HA in the WT lane. (B) An immunoblot was carried out as in panel A with RZ53-6 rox1 and MZ255-6 transformed with YCp(22)ROX1HA (WT and rfx1, respectively), and RZ53-6 rox1 transformed with YCp(23)ROX1 (designated C). NQO induction was performed with the RZ53-6 rox1 transformed with YCp(33)ROX1HA for the times indicated. The relative levels of Rox1HA, calculated as described for panel A, are indicated below each lane.
|
cells. If Rox1 and Mot3 retained full repression activity during NQO induction, then there would be no increase in RNR-lacZ expression in the rfx1
strain. As can be seen in Fig. 5, this was the case; the expression of the three genes remained unchanged in the rfx1
mutant and the rox1
mot3
rfx1
control (rox1
rfx1
for RNR2, which is not repressed by Mot3) compared to the robust induction in wild-type cells. To compare the induction profiles, we normalized the enzyme activity to the fold induction, with the uninduced levels as 1.0. (It should be noted that the un-normalized levels were quite different for each strain as seen in Tables 3 to 5, and although the fold induction levels in the rfx1
and double and triple mutants remained close to 1.0 throughout induction as expected, the absolute levels were quite high.)
![]() View larger version (13K): [in a new window] |
FIG. 5. Rox1 and Mot3 retained repression activity during DNA damage. MZ233-20 (WT), MZ233-13 (rfx1 ), and MZ255-6 (rox1 rfx1 ) cells were transformed with YCp(33)RNR2Z (A), and MZ233-20 (WT), MZ233-13 (rfx1 ), and MZ269-8 (rox1 mot3 rfx1 ) cells were transformed with YCp(33)RNR3Z (B) or YCp(33)RNR4Z (C). The transformants were grown to mid-exponential phase in SC-uracil medium at 30°C with vigorous shaking. ß-Galactosidase assays were performed with samples taken before (time zero) and at the indicated times after the addition of NQO to a final concentration of 1.3 µM. The ß-galactosidase values were normalized to fold induction by dividing the activity at time zero into the activity at the indicated times for each strain.
|
The synergy between Rox1 and Mot3 is clearly evident (Table 8). Single Rox1 and Mot3 sites provided poor repression with either Rox1 (in mot3
cells) or Mot3 (in rox1
cells) but strong repression when both proteins were present (in wild-type cells). The synergy factor was more than 6. We also generated a series of constructs with the three other possible orientations of the nonpalindromic Rox1 and Mot3 sites with respect to each other, and a construct with a deletion of 5 bp between the two sites (changing the side of the helix to which the proteins bound). Synergy was evident in all cases (data not shown). This lack of orientation or spacing requirements again reinforces the conclusion that Rox1 and Mot3 do not interact directly, but through a larger, more flexible complex.
|
View this table: [in a new window] |
TABLE 8. Combinatorial repression with single Rox1 or Rfx1 and Mot3 sites
|
cells with the strong site reporter versus 2.6-fold repression in mot3
cells with the weak site reporter). In both cases, synergy was clearly evident, with a calculated synergy factor of 2.3 for the weak site and 3.4 for the strong site.
We integrated the AZ-M3Rfs reporter into the genome to ascertain that plasmid copy number effects were not influencing the measurements of synergy. The values obtained for the ß-galactosidase activities were 1.2 ± 0.3 (wild type), 20 ± 5 (mot3
), 249 ± 25 (rfx1
), and 642 ± 63 (mot3
frx1
). Again, these values agree well with but are not identical to those obtained with the centromeric plasmid. The synergy factor calculated from these values is 6.3, confirming the that Mot3 and Rfx1 can act synergistically.
To test the synergy between Rox1 and Rfx1, we constructed lacZ reporter genes containing single Rox1 plus Rfx1 sites. We used a weak Rfx1 site and inserted the Rox1 site in the two different orientations with respect to the Rfx1 site. The results of ß-galactosidase assays performed with wild-type, rox1
, rfx1
, and rox1
rfx1
transformants are presented in Table 9. It is evident from the data that the combined repression by Rox1 and Rfx1 was greater than that expected from additive repression alone; the synergy factor was about 3 independent of the orientation of the Rox1 site. Furthermore, although the orientation of the Rox1 site did appear to have a significant effect on repression, the fold repression was about three times greater for the Rox1 site in the inverted orientation both in the absence (rfx1
cells) and in the presence (wild-type cells) of Rfx1; there was no orientation dependence of the synergy factor. This observation also suggests that the two repressors do not interact directly. Thus, all of the evidence suggests that synergy involving Rox1, Rfx1, and Mot3 functions through indirect interactions.
|
View this table: [in a new window] |
TABLE 9. Combinatorial repression between Rox1 and Rfx1
|
strain and a rox1
mot3
strain to negate the effect of the Mot3 site present in OpA and the 3'
plasmids.
The results, presented in Table 10, indicate that two bound Rox1 molecules could not function synergistically. The Rox1 bound to the single 5' site in OpA
3' repressed the reporter gene expression 2.2-fold, while the Rox1 bound to the 3' Rox1 site in OpA
5' repressed reporter gene expression 3.7-fold. The product of these two effects would give an additive repression of 8.1-fold for two Rox1 molecules bound to two sites functioning independently. The measured fold repression for the wild-type OpA was 9.7-fold, which is nearly the same as that for additive repression.
|
View this table: [in a new window] |
TABLE 10. Combinatorial repression between two Rox1 molecules
|
Rfx1 sites are most often present in pairs, with one strong and one weak site in the upstream region of genes (for examples, see Fig. 1). However, these sites are quite far apart. To determine whether two closely spaced Rfx1 sites could act combinatorially, YCp(33)AZ-2Rf was constructed containing two weak Rfx1 sites 10 bp apart (Table 2). This plasmid was transformed into the mot3
and mot3
rfx1
strains. For a single Rfx1 site, the plasmid YCp(33)AZ-M3Rfw, containing the same Rfx1 site and a Mot3 site, was transformed into the same strains. Since both strains contained the mot3
deletion, the lacZ expression from the two plasmids would provide the fold repression for one and two Rfx1 sites. RFX1 cells carrying the plasmid with two Rfx1 sites contained 239 ± 14 Miller units, whereas rfx1
cells carrying the same plasmid contained 459 ± 28 Miller units, a 1.9-fold repression. The plasmid carrying only one Rfx1 site gave a 2.6-fold repression (Table 5). Thus, two weak Rfx1 sites positioned 10 bp apart could not even function additively in repression. Perhaps two Rfx1 molecules could not bind simultaneously or could not recruit additional Ssn6/Tup1 molecules. In any event these results and those with two Rox1 and two Mot3 sites indicate that synergy appears to be limited to heterologous proteins.
|
|
|---|
We observed repression by Mot3 at RNR3 and -4 and by Rox1 at RNR2, -3, and -4. These genes encode three of the four proteins of RNR and are repressed by Rfx1. The gene encoding the fourth protein, RNR1, is not repressed by Rfx1 (22) and contains no Rox1 or Mot3 sites. Nor was the expression of an RNR1-lacZ fusion altered in the triple deletion (K. Cartmill and R. Zitomer, unpublished results). Ribonucleotide reductase is comprised of a large and a small subunit (25). Rnr2 and -4 form the small subunit in yeast, and Rnr2 contains a diferric tyrosyl radical center required for catalysis (5, 17). Formation of the tyrosyl radical requires molecular oxygen and is facilitated by Rnr4 (5, 17). Hence the reason for the regulation of RNR2 and -4 by Rox1 and Mot3 may be to increase the levels of protein to drive radical formation under hypoxic conditions. (It should be noted that there is a hypothetical 138 codon open reading frame 155 bp upstream from RNR2 which, if authentic, would share a regulatory region with RNR2.) The large subunit is composed of Rnr1 homodimers under normal growth conditions, whereas Rnr3 represents an alternative large subunit protein induced during DNA damage (15). The role that Rnr3 might play under hypoxia is unclear, but Rnr1-Rnr3 heterodimers are more active in vitro (11), and the hypoxic induction of Rnr3 may function to increase RNR activity as formation of the holoenzyme becomes compromised.
The synergy among differentially regulated repressors reported here has great biological import. It allows strong repression of a gene through the action of two (or three) weakly acting repressors, yet the loss of repression by only one allows substantial derepression. Thus, multiple repressors functioning at a single gene do not have to be coordinately regulated to achieve robust induction in response to only one signal; the loss of synergy achieves that end. For the repressors studied here, Rox1 and Mot3 syntheses are regulated positively by oxygen, while Rfx1 activity is negatively regulated by DNA damage. We presented evidence here that there was little, if any, cross-regulation; Rox1 and Mot3 were fully functional during DNA damage, and Rfx1 retained full activity during hypoxia. Nonetheless, during DNA damage, a substantial part of Rox1 and Mot3 repression of the RNR genes was lost because the synergy with Rfx1 was lost. RNR4 regulation presents a good example of this phenomenon as seen in the data in Table 5. RNR4 expression was repressed 37-fold by the combination of the three repressors (comparing the triple deletion to the wild type). Rfx1 alone could repress expression only 2.7-fold (comparing the triple deletion to the rox1
mot3
mutant). Yet the loss of Rfx1 repression that might mimic DNA damage resulted in a 22-fold induction (comparing the rfx1
mutant to the wild type). Because of the loss of the combined synergy between Rfx1 and Rox1 and between Rfx1 and Mot3, nearly full induction was achieved. Similarly, under hypoxic conditions, simulated by the loss of Rox1 and Mot3 in the rox1
mot3
mutant, RNR4 was induced 14-fold due to the inability of Rfx1 to strongly repress in their absence. Furthermore, since synergy is indirect, functioning through Ssn6, the evolution of synergy in this system did not even require the acquisition of direct interactions among these proteins. The only requirement for the introduction of this type of synergy in a system is the acquisition of closely spaced binding sites. Thus, we anticipate that many other examples of this biological phenomenon will be discovered. It should be noted, however, that these systems can be quite well disguised; elegant studies of Rfx1 repression of the RNR genes gave no clue that the robust repression by Rfx1 actually required the presence of two other proteins at the genes (22).
To explore the nature of synergy further, we devised artificial constructs in which we could control the number and relative positions of the repressor binding sites with respect to each other while holding the upstream activation sites, TATA box, and all other upstream sequences constant. Using single binding sites for each repressor, these constructs demonstrated the synergy between pairwise combinations. Interestingly, Mot3 acted synergistically equally well with strong and weak Rfx1 sites, suggesting that Mot3 was not simply helping Rfx1 bind better to weak sites. This conclusion fits well with our model of Rox1-Mot3 synergy in which Mot3 helps Rox1 recruit Ssn6; perhaps Mot3 is functioning in the same capacity with Rfx1. In addition, synergy is independent of the orientation of the asymmetric Rox1 and Mot3 sites and the Rox1 and Rfx1 sites, reinforcing the model that synergy does not require direct contact between the DNA-binding repressors. Interestingly, synergy was not previously observed between closely spaced Mot3 molecules or, in the present study, between closely spaced Rox1 or Rfx1 molecules. Thus, it appears that synergy is limited to heterologous repressors. This conclusion supports our previously proposed model in which the synergy arises from the sharing of Ssn6/Tup1 complexes by Rox1 and Mot3. The requirement for heterology in this model arises because the two repressors must contact different surfaces of Ssn6.
There are at least two other examples in the literature of two different Ssn6-Tup1 recruiting repressors regulating the same genes. Proft and Serrano (39) reported that the ENA1 gene was repressed by Sko1, a repressor of osmotically induced genes, and Mig1/Mig2, repressors of glucose-repressed genes. The binding sites for Sko1 and Mig1/Mig2 are 20 bp apart. While the authors did not address the question of additive or synergistic repression directly, data presented in Table 3 concerning the expression of an ENA1-lacZ fusion in wild-type, sko1
, mig1
mig2
, and triple sko1
mig1
mig2
cells allow the calculation of a synergy factor of 3.1. Thus, it appears that Sko1 can act synergistically with Mig1 and Mig2. In the second example, the Ssn6/Tup1 recruiting repressors Rim101, a repressor of meiotic genes, and Nrg1, a repressor of glucose-repressed genes, were demonstrated to repress the divergently transcribed DIT1-DIT2 genes (42). Both repressors bound to a 40-bp fragment between the two genes. This fragment was inserted upstream of the CYC1-lacZ gene, and expression studies presented in Fig. 7 of reference 42 allow the calculation of a Synergy Factor of 1, indicating that Nrg1 and Rim101 did not act synergistically. These two examples suggest that some, but not all Ssn6/Tup1 recruiting repressors can act synergistically.
We thank Marjorie Zitomer for strain constructions.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»